- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07857811
Evaluation of Aortic-Radial Blood Pressure Gradient in Pediatric Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass (GARP)
Invasive blood pressure monitoring is essential during heart surgery. Usually, doctors measure blood pressure using a small tube (a catheter) placed in an artery, typically in the wrist or arm. During surgeries that require a heart-lung machine (cardiopulmonary bypass), doctors can also measure blood pressure directly near the heart in the main artery (the aorta). This is done using a tube already in place for the machine, so no extra procedure is needed.
In adult patients, doctors have noticed that blood pressure readings taken at the arm can sometimes be significantly different from readings taken near the heart right after coming off the heart-lung machine. This difference could lead to unnecessary or incorrect treatments if medical teams rely only on arm readings. However, it is still unknown whether this same difference occurs in children.
The goal of this study is to measure and compare blood pressure from both the arm and near the heart in children aged 3 years and younger as they come off the heart-lung machine during heart surgery. This research will help medical teams make safer, more accurate treatment decisions for children undergoing heart surgery.
Study Overview
Status
Intervention / Treatment
Detailed Description
Accurate arterial blood pressure monitoring is essential during and after cardiopulmonary bypass (CPB) in pediatric cardiac surgery. However, a significant gradient between radial and central aortic pressure has been reported, which could lead to erroneous clinical decisions if radial pressure is overestimated. Although this phenomenon has been studied in adults, its incidence, associated factors, and clinical implications in pediatric patients under 3 years of age remain to be clearly established.
This study proposes a prospective observational cohort design including 100 patients under 3 years of age undergoing cardiac surgery with CPB and invasive radial arterial monitoring. The study will evaluate the incidence of a significant radial-to-aortic gradient (defined as a >20% difference in SBP or >10% in MAP sustained for more than 5 minutes), alongside biometric and surgical risk factors, and its relationship with clinical outcomes such as vasoactive drug requirements, blood transfusions, and duration of mechanical ventilation.
Statistical analysis will be performed using descriptive statistics, bivariate testing, and multivariate LASSO logistic regression. This study is expected to identify a pediatric risk profile for developing a significant pressure gradient, thereby optimizing decision-making regarding arterial monitoring sites and post-CPB hemodynamic management. Ultimately, this research aims to address a clinically relevant knowledge gap and enhance perioperative safety in this highly vulnerable population.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Santiago Arze, MD
- Phone Number: +56955049217
- Email: sarze@uc.cl
Study Contact Backup
- Name: Valeria Pizarro, MD
- Phone Number: +56962283715
- Email: vale.pizarro@uc.cl
Study Locations
-
-
Santiago Metropolitan
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Recruiting
- Pontificia Universidad Católica de Chile
-
Santiago, Santiago Metropolitan, Chile, 8320000
- Recruiting
- Red de Salud UC Christus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Pediatric patients from 0-3 years of age
Description
Inclusion Criteria:
- Patients from 0 to 3 years old
- Cardiac surgery with cardiopulmonary bypass (CPB)
- Invasive blood pressure monitoring via radial artery
Exclusion Criteria:
- Patients in whom radial cannulation is not achieved
- Significant vascular malformations that may interfere with or contraindicate invasive radial blood pressure measurement
- Emergency surgeries
- Reinterventions during the same hospital stay
- Technical complications preventing reliable direct aortic pressure measurement
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study group
Patients under 3 years of age undergoing cardiac surgery with cardiopulmonary bypass (CPB) at the UC-Christus Clinical Hospital. |
Placement of a pressure transducer at the accessory port of the cardiopulmonary bypass (CPB) arterial cannula during the final phase of CPB and the immediate post-CPB period. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate the occurrence of a significant radial-to-aortic (R-Ao) pressure gradient during the immediate post-cardiopulmonary bypass (CPB) period
Time Frame: within 15 minutes from the weaning of the CBP
|
A significant radial-to-aortic (R-Ao) pressure gradient is defined as a >20% difference in SBP or >10% difference in MAP sustained for >5 minutes) during the immediate post-cardiopulmonary bypass (CPB) period |
within 15 minutes from the weaning of the CBP
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To determine the incidence of the R-Ao gradient in pediatric patients undergoing cardiac surgery with CPB and compare it with reported rates in the adult literature.
Time Frame: Within the first 15 minutes after CPB weaning.
|
R-Ao Gradient Incidence: percentage of positive finding to the total of recruited patients in the study. Reported Rates in adult population: As per an exhaustive review of previous literature. |
Within the first 15 minutes after CPB weaning.
|
|
To identify risk factors associated with a higher R-Ao gradient, based on patient biometric parameters and surgical variables
Time Frame: From enrollment to 48 hours after surgery
|
Patient variables: age, body surface area [BSA], radial artery diameter Surgery variables: CPB duration and use of hypothermia Outcome Measure: Odds Ratio |
From enrollment to 48 hours after surgery
|
|
To compare vasoactive drug requirements/dosages between patients with and without a significant arterial gradient
Time Frame: within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
The comparison will be made using VIS score, as: VIS = dopamine + dobutamine + (100 × epinephrine) + (100 × norepinephrine) + (10 × milrinone) + (10,000 × vasopressin) It will be measured at three time periods: 30 mins post CPB, Postoperative Day 1 and Postoperative Day 2 |
within 30 minutes from the weaning of the CBP, up to 48 hours after surgery.
|
|
To compare the duration of invasive mechanical ventilation between patients with and without a significant arterial gradient.
Time Frame: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of post-CPB blood transfusion between patients with and without a significant arterial gradient.
Time Frame: within the first 48 hours following weaning of the CBP
|
within the first 48 hours following weaning of the CBP
|
|
|
To compare the incidence of renal dysfunction between patients with and without a significant arterial gradient.
Time Frame: within 48 hours following weaning of the CBP
|
within 48 hours following weaning of the CBP
|
Collaborators and Investigators
Investigators
- Principal Investigator: Santiago Arze, MD, División de Anestesiología, Pontificia Universidad Católica de Chile
Publications and helpful links
General Publications
- Stern DH, Gerson JI, Allen FB, Parker FB. Can we trust the direct radial artery pressure immediately following cardiopulmonary bypass? Anesthesiology. 1985 May;62(5):557-61. doi: 10.1097/00000542-198505000-00002.
- Jacquet-Lagreze M, Costescu A, Denault A. Can we trust radial artery pressure monitoring for cardiac surgery? Can J Anaesth. 2022 Nov;69(11):1319-1326. doi: 10.1007/s12630-022-02321-1. Epub 2022 Oct 5. No abstract available.
- Bouchard-Dechene V, Kontar L, Couture P, Perusse P, Levesque S, Lamarche Y, Denault AY; Montreal Heart Institute Research Team. Radial-to-femoral pressure gradient quantification in cardiac surgery. JTCVS Open. 2021 Aug 5;8:446-460. doi: 10.1016/j.xjon.2021.07.031. eCollection 2021 Dec.
- Dhanyee AS, Parida S, Thangaswamy CR, Jha AK, Rajappa M, Munuswamy H, Mishra SK. Relationship between difference of preoperative and cardiopulmonary bypass mean arterial pressure, and acute kidney injury in cardiac surgical patients undergoing valve surgery. Perfusion. 2025 Jan;40(1):164-173. doi: 10.1177/02676591231226161. Epub 2024 Jan 5.
- Oh AR, Hong KY, Park J, Her S, Lee JH. Risk factors for femoral-to-radial artery pressure gradient after weaning from cardiopulmonary bypass: a historical cohort study. Can J Anaesth. 2022 Nov;69(11):1330-1339. doi: 10.1007/s12630-022-02320-2. Epub 2022 Oct 6.
- Pauca AL, Hudspeth AS, Wallenhaupt SL, Tucker WY, Kon ND, Mills SA, Cordell AR. Radial artery-to-aorta pressure difference after discontinuation of cardiopulmonary bypass. Anesthesiology. 1989 Jun;70(6):935-41. doi: 10.1097/00000542-198906000-00009.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 250425011
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.